Praxis Precision Medicines used its investor day to lay out its commercial strategy and signal a broader pipeline expansion. The company detailed launch plans f

BWB News TV • 2026-11-12 22:22 UTC • By Billy Odell Tucker-Robinson

Praxis Precision Medicines used its investor day to lay out its commercial strategy and signal a broader pipeline expansion. The company detailed launch plans for relutrigine in SCN2A and SCN8A DEEs and ulixacaltamide in essential tremor.

Share this article

𝕏 X / Twitter Facebook LinkedIn WhatsApp

📚 More from Billy’s World

📰 Banking With Billy News All breaking financial news & market analysis 📚 Banking With Billy Books Deep-dive books on every financial story 💬 Join the Community discord.gg/VHxwmR5j4Y 🎥 Banking With Billy on YouTube Live streams & market commentary

Banking With Billy News Network — bankingwithbilly.com
Discord: discord.gg/VHxwmR5j4Y • YouTube: @BankingWithBilly